WinstonWınston
Bastide Le Confort Médical S.A. logo

Bastide Le Confort Médical S.A.

BLC.PA
43
Medical - Care Facilities · Healthcare
Also trades as: 0IP1.L
Price
€22.60
+0.10 (+0.44%)
Market Cap
€165.2M
Exchange
Euronext Paris
Winston Score
43
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 12, 2026 · filings through Dec 31, 2025

Share count rising — dilution

+7.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 7.4M (2021) → 7.9M (2025)

Bastide Le Confort Médical is a French company that provides medical equipment and home healthcare services to patients who need ongoing care outside of a hospital. Its core services include supplying oxygen therapy, sleep apnea devices, wheelchairs, and other mobility or respiratory equipment directly to patients at home. The company works closely with doctors, hospitals, and French social security to deliver and maintain this equipment for people with chronic conditions.

Bastide earns revenue mainly through long-term service contracts and equipment rentals, with French public health insurance reimbursing a large share of costs. It operates almost entirely in France, with some presence in other European markets, and its established network of local service branches creates a barrier for new competitors to replicate quickly. The main risk the company faces is its heavy dependence on French government reimbursement rates, which regulators can reduce, directly squeezing the margins that are already thin at around 10 percent.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
10.9%
Thin — 10.9% gross margin
Operating Margin
9.0%
Modest — 9.0% operating margin
ROCE
6.3%
Weak — 6.3% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-11.9%
Shrinking sales (-11.9% YoY)
EPS YoY
>+1,000%
Earnings growing fast (>+1,000% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
268%
Turns 268% of profit into real cash
FCF Margin
6.3%
Modest free cash flow (6.3%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
2.63
Heavy debt load (2.63)
Interest Cover
1.53x
Dangerous — barely covers interest (1.5x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
5.7x
Attractive valuation — P/E 5.7

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
-7.7
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial